ShotBlocker ‫مجموعات‬ ‫في‬ ‫أقل‬ VAS ‫درجات‬ ‫كانت‬ ‫النتائج:‬ ‫التحكم‬ ‫مجموعة‬ ‫في‬ ‫عنها‬ ‫مم)‬ 10( ‫البارد‬ ‫والرذاذ‬ ‫مم)‬ 11( ‫كبير‬ ‫‪VAS‬بشكل‬ ‫درجات‬ ‫تختلف‬ ‫لم‬ .)p=0.001( ‫مم)‬ 31( ‫ردود‬ ‫كشفت‬ ‫البارد.‬ ‫الرذاذ‬ ‫ومجموعات‬ ShotBlocker ‫بني‬ ‫الرش‬ ‫من‬ ‫أكثر‬ ‫إدارته‬ ‫الصعب‬ ‫من‬ ‫كان‬ ShotBlocker ‫أن‬ ‫املشغلني‬ ‫البارد.‬ ‫من‬ ‫تقلل‬ ‫فعالة‬ ‫دوائية‬ ‫غير‬ ‫وسيلة‬ ‫هو‬ ShotBlocker ‫اخلالصة:‬ ‫الرذاذ‬ ‫فعالية‬ ‫فعاليته‬ ‫وتشبه‬ IM ‫العضلي‬ ‫باحلقن‬ ‫املرتبط‬ ‫األلم‬ ‫البارد.‬ Objectives: To compare the efficacy of ShotBlocker and cold spray in reducing intramuscular (IM) injection-related pain in adults.

No abstract

In predicting neurological outcomes, serum S-100B has high sensitivity and low specificity immediately after CPR.

BACKGROUND: Endotracheal intubation (ETI) procedure in the combat area differs from prehospital trauma life support procedures because of the danger of gunfire and the dark environment. We aimed to determine the success, difficulty degree, and duration of ETI procedures with a classical laryngoscope (CL) in a bright room and with a modified laryngoscope (ML) model in a dark room.

Blue light offered the best tactical safety during intravenous cannulation under night-time conditions and is recommended for future use in tactical casualty care. The use of NVGs using infrared light cannot be recommended if there is the possibility of opponents having access to the technology.

Considering this finding, we still strongly recommend that it would be relatively safer to open the ML blade inside the mouth and to perform the procedures under a PL. In chaotic environments where it might become necessary to provide civilian health services for humanitarian aid purposes (Red Crescent, Red Cross, etc.) without NVGs, we believe that it would be relatively safer to open the CL blade inside the mouth and to perform the procedures under a PL.

Objective Coronavirus disease 2019 (COVID‐19) is an emerging, fast‐spreading, highly mortal and worldwide infectious disease. The pulmonary system was defined as the main target of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but the mortality concept of this disease presented with more severe and systemic disease. The present study investigated the relationship between the patient characteristics at the initial hospital administration and fatality in COVID‐19 patients. Methods In this retrospective and comparative cohort study, all the 767 hospitalised COVID‐19 patients, treated between 18 March and 15 May 2020 in the Covid Clinics of Gulhane Training and Research Hospital in Ankara, Turkey, were evaluated. Results The fatality rate was significantly increased in patients with any comorbid disease except asthma. The initial laboratory test results indicated highly significant differences according to the patient's outcome. A multifactor logistic regression analysis was performed to calculate the adjusted odds ratios for predicting patient outcomes. Being older than 60 years increased the death risk with an adjusted OR of 7.2 (95% CI: 2.23‐23.51; P = .001). The presence of a cancer and the extended duration of intensive care unit treatment were other significant risk factors for nonsurvival. Azithromycin treatment was determined as significantly reduced the death ratio in these patients ( P = .002). Conclusion It was revealed that being older than 60 years, presence of a cancer and extended duration of ICU treatment were the major risk factors for predicting fatality rate in hospitalised COVID‐19 patients.

No abstract